Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,023,967
  • Shares Outstanding, K 107,786
  • Annual Sales, $ 260,980 K
  • Annual Income, $ -40,450 K
  • 60-Month Beta 1.84
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book 11.82
Trade ORGO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.01
  • Low Estimate 0.00
  • Prior Year -0.04
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.19 +83.04%
on 12/16/20
10.51 -9.61%
on 01/14/21
+4.10 (+75.93%)
since 12/15/20
3-Month
3.45 +175.73%
on 10/29/20
10.51 -9.61%
on 01/14/21
+4.92 (+107.42%)
since 10/15/20
52-Week
2.47 +284.27%
on 03/18/20
10.51 -9.61%
on 01/14/21
+4.30 (+82.69%)
since 01/15/20

Most Recent Stories

More News
Thinking about buying stock in GameStop, Virgin Galactic, Ur-Energy, Polarityte, or Organogenesis Holdings?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GME, SPCE, URG, PTE, and ORGO.

URG : 1.0700 (-10.08%)
ORGO : 9.50 (+0.11%)
PTE : 1.0800 (-10.74%)
GME : 35.50 (-11.05%)
SPCE : 30.43 (-7.87%)
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%

Corbus Pharmaceuticals (CRBP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

CRBP : 1.7400 (unch)
ORGO : 9.50 (+0.11%)
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu(R) for Knee Osteoarthritis

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical...

ORGO : 9.50 (+0.11%)
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical...

ORGO : 9.50 (+0.11%)
Organogenesis ReNu(R) Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee

FDA Determines ReNu Preliminary Clinical Evidence Indicates Potential to Address Unmet Medical Needs for the Management of Symptoms Associated with Knee Osteoarthritis

ORGO : 9.50 (+0.11%)
Why Nasdaq Can Win Again in 2021 After the Best Year Since 2009

New strain of coronavirus, growing demand for digitization and past record indicate that the Nasdaq can win in 2021 too after its best year since 2009.

UCTT : 40.03 (+0.55%)
COHU : 45.22 (-2.27%)
SPY : 375.70 (-0.73%)
AEIS : 115.47 (-1.89%)
QQQ : 311.86 (-0.79%)
IWM : 210.75 (-1.49%)
AOSL : 28.37 (-4.16%)
ORGO : 9.50 (+0.11%)
Earnings Estimates Rising for Organogenesis (ORGO): Will It Gain?

Organogenesis (ORGO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ORGO : 9.50 (+0.11%)
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical...

MS : 75.24 (-1.61%)
ORGO : 9.50 (+0.11%)
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical...

MS : 75.24 (-1.61%)
ORGO : 9.50 (+0.11%)
Organogenesis Holdings Inc. Updates Date and Time of Presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical...

MHMNF : 54.5000 (unch)
ORGO : 9.50 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 10.47
2nd Resistance Point 10.07
1st Resistance Point 9.79
Last Price 9.50
1st Support Level 9.11
2nd Support Level 8.71
3rd Support Level 8.43

See More

52-Week High 10.51
Last Price 9.50
Fibonacci 61.8% 7.44
Fibonacci 50% 6.49
Fibonacci 38.2% 5.54
52-Week Low 2.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar